Chemours' Earnings Outpace Estimates, Revenues Miss in Q4

Core Insights - The Chemours Company reported a net loss of $8 million or 5 cents per share for Q4 2024, an improvement from a loss of $18 million or 12 cents in the same quarter last year [1] - Adjusted earnings came in at 11 cents per share, beating the Zacks Consensus Estimate of 10 cents [1] - Fourth-quarter net sales were $1,359 million, reflecting a 1% decline year-over-year, falling short of the Zacks Consensus Estimate of $1,359.8 million [2] Financial Performance - Adjusted EBITDA rose 2% year-over-year to $179 million, driven by cost savings from the Titanium Technologies Transformation Plan and increased volumes in Thermal & Specialized Solutions [3] - For FY 2024, net sales totaled $5,782 million, a decline of 4.9% from the previous year, with adjusted net income dropping to $182 million from $425 million [7] - Cash provided by operating activities in Q4 2024 was $138 million, down from $482 million in the prior-year quarter [8] Segment Performance - The Titanium Technologies division reported revenues of $632 million, a 3% decrease from the previous year, primarily due to a 2% decrease in pricing and a 1% fall in volume [4] - The Thermal & Specialized Solutions segment saw a 3% year-over-year revenue increase to $390 million, driven by a 7% increase in volume, although it fell short of estimates [5] - Advanced Performance Materials revenues amounted to $324 million, a decline of approximately 1% year-over-year, primarily due to a 3% drop in price [6] Outlook - The company expects full-year 2025 adjusted EBITDA to be between $825 million and $975 million, with capital expenditures projected between $250 million and $300 million [10] Stock Performance - Chemours shares have decreased by 39.7% over the past year, contrasting with a 0.8% decline in the industry [11]